Related Posts
- Total metabolic tumor volume on 18F-FDG PET/CT is a game-changer for patients with metastatic lung cancer treated with immunotherapy
Purpose Because of atypical response imaging patterns in patients with metastatic non-small cell lung cancer…
- 1401 PLT012, a monoclonal antibody targeting CD36, unleashes anti-tumor immunity via metabolic reprogramming in tumor microenvironment
Background Accumulation of lipid metabolic products in tumor microenvironment (TME) has been documented to augment…